J Pediatr Infect Dis 2019; 14(05): 248-252
DOI: 10.1055/s-0039-1692676
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Efficacy and Side Effects of Topical Applications of Two Different Solutions in the Treatment of Molluscum Contagiosum in a City in Africa: An Open, Randomized, Comparative Clinical Trial

1   Department of Dermatology, Umraniye Training and Research Hospital, Istanbul, Turkey
› Institutsangaben
Weitere Informationen

Publikationsverlauf

28. Februar 2019

17. Mai 2019

Publikationsdatum:
21. Juni 2019 (online)

Abstract

Molluscum contagiosum (MC) is one of the most common viral infections in African children. However, there is no work investigating the treatment of MC in dark skinned children in Africa. In this study, we aimed to compare efficacy and side effects of topical application of 10% potassium hydroxide (KOH) and 16.7% salicylic acid (SAL) and lactic acid (LAC) combination in the treatment of MC in Sudan, Africa. This is a prospective, randomized, and comparative study. The inclusion criterion was the presence of at least 10 lesions. The exclusion criteria were the use of any topical MC treatment during the last 2 weeks, immunosuppression, periorbital and perioral involvement, the history of hypersensitivity to any kind of keratolytics, and the presence of concomitant bacterial skin infections. The main efficacy outcome was the complete remission or partial remission. Three visits were performed: baseline visit (diagnosis, randomization, and therapy initiation), visit 1 for follow-up (at 15–30 days after initiation of therapy and for study end), and visit 2 for postclearing assessment (at 60th day after the initiation of therapy). Chi-squared (χ2) test was used. All patients (n = 101) participating completed the 60 days of follow-up period. Post 60 days of treatment, the rates of complete resolution in 55 patients treated with 10% KOH solution and 47 patients treated with 16.7% SAL + LAC combination solution were 87.0 and 85.1% (p > 0.05), respectively. The rates of partial resolution in the group treated with KOH solution and in patients treated with SAL + LAC combination solution were 12.9% and 14.8% (p > 0.05), respectively. Major side effects in KOH group were burning sensation or stinging during application (48.1%, p = 0.0009) and hypopigmentation (38.8%, p = 0.007) while it was desquamation (23.4%, p > 0.05) in the SAL + LAC combination group. Results indicate both 10% KOH solution and SAL + LAC combination solution showed good efficacy in the treatment of MC in African children. Neither 10% KOH nor the SAL + LAC combination solution was found superior to other in the treatment, while the latter was noted to have fewer side effects. Permanent hypopigmentation is an important and undesired side effect of 10% KOH treatment.

 
  • References

  • 1 Müller CSL, Laue M, Kremer K, Becker S, Vogt T, Smola S. Molluscum-contagiosum-virus in einer epidermalzyste. J Dtsch Dermatol Ges 2018; 16 (09) 1144-1146
  • 2 Clebak KT, Malone MA. Skin infections. Prim Care 2018; 45 (03) 433-454
  • 3 Dave D, Abdelmaksoud A. Glycolic acid cream for treatment of molluscum contagiosum. Dermatol Ther (Heidelb) 2018; 31 (05) e12630
  • 4 Schianchi R, Nazzaro G, Veraldi S. Treatment of molluscum contagiosum with hydrogen peroxide. Clin Exp Dermatol 2018; 43 (01) 66-67
  • 5 Rush J, Dinulos JG. Childhood skin and soft tissue infections: new discoveries and guidelines regarding the management of bacterial soft tissue infections, molluscum contagiosum, and warts. Curr Opin Pediatr 2016; 28 (02) 250-257
  • 6 van der Wouden JC, van der Sande R, Kruithof EJ, Sollie A, van Suijlekom-Smit LW, Koning S. Interventions for cutaneous molluscum contagiosum. Cochrane Database Syst Rev 2017; 5: CD004767
  • 7 Romiti R, Ribeiro AP, Grinblat BM, Rivitti EA, Romiti N. Treatment of molluscum contagiosum with potassium hydroxide: a clinical approach in 35 children. Pediatr Dermatol 1999; 16 (03) 228-231
  • 8 Giner-Soriano M, Teixidó C, Marsal JR. , et al; Working Group for the Clinical Trial IJG-KOH-2014. Randomized placebo-controlled clinical trial on efficacy and safety of topical 10% potassium hydroxide for molluscum contagiosum treatment in children. J Dermatolog Treat 2019; 1-7 (e-pub ahead of print). doi: 10.1080/09546634.2019.1573305
  • 9 Huu SN, Quang MN, Van TN. , et al. Efficacy of 10% potassium hydroxide solution versus 10% salicylic acid ointment in treatment of molluscum contagiosum - the low - cost dermatologic therapy in Vietnam. Open Access Maced J Med Sci 2019; 7 (02) 269-271
  • 10 Teixidó C, Díez O, Marsal JR. , et al. Efficacy and safety of topical application of 15% and 10% potassium hydroxide for the treatment of molluscum contagiosum. Pediatr Dermatol 2018; 35 (03) 336-342
  • 11 Nameer K, Al-Sudany A, Abdulkareem DR. A comparative study of topical 10% KOH solution and topical 25% podophyllin solution as home-based treatments of molluscum contagiosum. J Dermatol Dermatol Surg 2016; 20: 107-114
  • 12 Chathra N, Sukumar D, Bhat RM. , et al. A comparative study of 10% KOH solution and 5% imiquimod cream for the treatment of molluscum contagiosum in the pediatric age group. Indian Dermatol Online J 2015; 6 (02) 75-80
  • 13 Handjani F, Behazin E, Sadati MS. Comparison of 10% potassium hydroxide solution versus cryotherapy in the treatment of molluscum contagiosum: an open randomized clinical trial. J Dermatolog Treat 2014; 25 (03) 249-250
  • 14 Ucmak D, Akkurt MZ, Kacar SD. , et al. Comparative study of 5% and 2.5% potassium hydroxide solution for molluscum contagiosum in children. Cutan Ocul Toxicol 2013; 3 (01) 54-59
  • 15 Köse O, Özmen İ, Arca E. An open, comparative study of 10% potassium hydroxide solution versus salicylic and lactic acid combination in the treatment of molluscum contagiosum in children. J Dermatolog Treat 2013; 24 (04) 300-304
  • 16 Rajouria EA, Amatya A, Karn D. Comparative study of 5% potassium hydroxide solution versus 0.05% tretinoin cream for molluscum contagiosum in children. Kathmandu Univ Med J (KUMJ) 2012; 9 (36) 291-294
  • 17 Can B, Topaloğlu F, Kavala M, Turkoglu Z, Zindancı I, Sudogan S. Treatment of pediatric molluscum contagiosum with 10% potassium hydroxide solution. J Dermatolog Treat 2014; 25 (03) 246-248
  • 18 Marsal JR, Cruz I, Teixido C. , et al. Efficacy and tolerance of the topical application of potassium hydroxide (10% and 15%) in the treatment of molluscum contagiosum: randomized clinical trial: research protocol. BMC Infect Dis 2011; 11: 278
  • 19 Seo SH, Chin HW, Jeong DW, Sung HW. An open, randomized, comparative clinical and histological study of imiquimod 5% cream versus 10% potassium hydroxide solution in the treatment of molluscum contagiosum. Ann Dermatol 2010; 22 (02) 156-162
  • 20 Metkar A, Pande S, Khopkar U. An open, nonrandomized, comparative study of imiquimod 5% cream versus 10% potassium hydroxide solution in the treatment of molluscum contagiosum. Indian J Dermatol Venereol Leprol 2008; 74 (06) 614-618
  • 21 Short KA, Fuller LC, Higgins EM. Double-blind, randomized, placebo-controlled trial of the use of topical 10% potassium hydroxide solution in the treatment of molluscumcontagiosum. Pediatr Dermatol 2006; 23: 279-281
  • 22 Mahajan BB, Pall A, Gupta RR. Topical 20% KOH--an effective therapeutic modality for moluscum contagiosum in children. Indian J Dermatol Venereol Leprol 2003; 69 (02) 175-177
  • 23 Ohkuma M. Molluscum contagiosum treated with iodine solution and salicylic acid plaster. Int J Dermatol 1990; 29 (06) 443-445
  • 24 Silverberg N. Pediatric molluscum contagiosum: optimal treatment strategies. Paediatr Drugs 2003; 5 (08) 505-512
  • 25 Hanna D, Hatami A, Powell J. , et al. A prospective randomized trial comparing the efficacy and adverse effects of four recognized treatments of molluscum contagiosum in children. Pediatr Dermatol 2006; 23 (06) 574-579
  • 26 Leslie KS, Dootson G, Sterling JC. Topical salicylic acid gel as a treatment for molluscum contagiosum in children. J Dermatolog Treat 2005; 16 (5-6): 336-340
  • 27 Brasch J, Becker D, Aberer W. , et al. Guideline contact dermatitis: S1-Guidelines of the German Contact Allergy Group (DKG) of the German Dermatology Society (DDG), the Information Network of Dermatological Clinics (IVDK), the German Society for Allergology and Clinical Immunology (DGAKI), the Working Group for Occupational and Environmental Dermatology (ABD) of the DDG, the Medical Association of German Allergologists (AeDA), the Professional Association of German Dermatologists (BVDD) and the DDG. Allergo J Int 2014; 23 (04) 126-138
  • 28 Manti S, Amorini M, Cuppari C. , et al. Filaggrin mutations and molluscum contagiosum skin infection in patients with atopic dermatitis. Ann Allergy Asthma Immunol 2017; 119 (05) 446-451
  • 29 Seize MB, Ianhez M, Cestari Sda C. A study of the correlation between molluscum contagiosum and atopic dermatitis in children. An Bras Dermatol 2011; 86 (04) 663-668
  • 30 Osio A, Deslandes E, Saada V, Morel P, Guibal F. Clinical characteristics of molluscum contagiosum in children in a private dermatology practice in the greater Paris area, France: a prospective study in 661 patients. Dermatology 2011; 222 (04) 314-320
  • 31 Kakourou T, Zachariades A, Anastasiou T, Architectonidou E, Georgala S, Theodoridou M. Molluscum contagiosum in Greek children: a case series. Int J Dermatol 2005; 44 (03) 221-223